Home›Companies›Biotech & Pharma›Opprtna Therapeutics

Opprtna Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 31, 2024·Suggest an edit

About Opprtna Therapeutics

Opprtna Therapeutics is a private company based in Mansfield, Massachusetts, incorporated in 2023 in Delaware. It has reported $125,000 raised in one offering on Form D since October 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 8, 2024Oct 31, 2024$125,000of $500K target1$125KEquity, Debt, OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Opprtna Therapeutics's Form D filed Oct 31, 2024.

GI
Ganesh Iyer
President and director

Sources

  1. SECOpprtna Therapeutics, Inc. filing history